Foundayo Prescription in Fort Worth at DFWPMA

Looking for a Foundayo prescription in Fort Worth, Texas? Foundayo (orforglipron) is an oral GLP-1 weight-loss medication that requires careful medical evaluation because inappropriate prescribing or inadequate monitoring can lead to serious health complications.

At DFW Physicians Medical Associates (DFWPMA), our endocrinology, internal medicine, and family medicine physicians conduct comprehensive evaluations of weight-related health conditions, metabolic health, medical history, and treatment risks to determine if Foundayo is appropriate for you.

DFWPMA can also prescribe Foundayo to eligible patients when medically appropriate. Foundayo is FDA-approved for chronic weight management in adults with obesity or overweight accompanied by at least one weight-related medical condition. Unlike injectable GLP-1 medications, Foundayo is taken as a once-daily pill.

Book an appointment online or call (903) 957-0082 to contact our Fort Worth location.

Address: 📍 1220 W. Presidio St., Fort Worth, TX 76102
Click here to get directions

We accept many major insurance plans. Not sure if your plan is accepted?

Call (903) 957-0082 and our team can help verify coverage.

Why Choose DFWPMA for a Foundayo Prescription in Fort Worth?

DFW Physicians Medical Associates provides Foundayo prescription evaluations in Fort Worth through physicians experienced in endocrinology, metabolic health, chronic disease management, and comprehensive medical care. Our multispecialty approach supports individualized weight-management evaluations and ongoing medical supervision.

Patients seeking a Foundayo prescription at DFWPMA can benefit from:

  • Experienced Medical Providers: Access to endocrinology, internal medicine, and family medicine physicians experienced in metabolic health, diabetes care, and chronic disease management.
  • Comprehensive Eligibility Assessment: Evaluation of body mass index (BMI), weight-related conditions, medical history, and potential contraindications before prescribing Foundayo.
  • Weight and Metabolic Health Evaluation: Assessment of obesity, blood glucose, blood pressure, cholesterol, and other metabolic indicators when clinically appropriate.
  • Individualized Prescription Decisions: Treatment recommendations based on medical eligibility, weight-management goals, clinical risks, and overall health.
  • Medication Safety Screening: Review of thyroid cancer history, pancreatitis, gastrointestinal conditions, medication interactions, and other relevant risks.
  • Oral Medication Management: Guidance on daily Foundayo administration, dose adjustments, medication tolerance, and potential side effects.
  • Long-Term Weight Management: Ongoing evaluation of weight changes, metabolic health, treatment effectiveness, and sustainable lifestyle modifications.
  • Coordinated Multispecialty Care: Access to additional medical and behavioral health services when patients require comprehensive support for weight-related health concerns.

Foundayo is not appropriate for every patient seeking weight loss. Prescribing decisions require evaluating obesity-related health risks, potential adverse effects, contraindications, medication interactions, and alternative treatment options.

At DFWPMA, comprehensive medical evaluation and individualized treatment planning are central to determining whether Foundayo is an appropriate weight-management medication.

Schedule an appointment with DFWPMA Fort Worth to discuss Foundayo prescription eligibility and your weight-management options.

Meet Our Foundayo Prescription Providers in Fort Worth

DFWPMA Fort Worth offers Foundayo prescription evaluations through physicians whose clinical expertise includes endocrinology, internal medicine, family medicine, metabolic disorders, and chronic disease management. These providers can assess medical eligibility and determine whether Foundayo is appropriate.

Gitana Staskus, MD – Endocrinology

Dr. Gitana Staskus is a board-certified endocrinologist with more than 20 years of clinical experience diagnosing and treating endocrine and metabolic disorders in adults and older adults.

Her expertise includes weight management, metabolic disorders, type 1 and type 2 diabetes, thyroid conditions, hormone disorders, and osteoporosis. Dr. Staskus emphasizes individualized treatment planning, patient education, and long-term management of endocrine conditions.

Her specialized background in weight management and metabolic health is particularly relevant for patients seeking Foundayo prescription evaluations, including individuals with obesity and related metabolic conditions.

Soheila Hesami, MD – Internal Medicine

Dr. Soheila Hesami is a board-certified internal medicine physician with more than 20 years of experience providing comprehensive healthcare for adults and older adults.

Her clinical expertise includes diabetes care, hypertension, high cholesterol, chronic disease management, medication management, preventive medicine, and comprehensive health evaluations.

Dr. Hesami’s experience managing metabolic risk factors and chronic medical conditions supports Foundayo prescription evaluations, including assessment of obesity-related health concerns, medication safety, and individualized treatment planning.

Anisha Zaman, MD – Family Medicine

Dr. Anisha Zaman is a family medicine physician providing comprehensive outpatient care, preventive medicine, and chronic disease management in Fort Worth.

Her clinical background includes diabetes management, hypertension treatment, patient education, preventive healthcare, and lifestyle-focused medical care. She completed her family medicine residency at the University of Arkansas for Medical Sciences.

Dr. Zaman’s experience in chronic disease management and preventive healthcare supports medical evaluations for patients considering Foundayo, including assessment of weight-related conditions, treatment eligibility, and long-term health goals.

Michael Huang, MD – Family Medicine

Dr. Michael Huang is a board-certified family medicine physician with more than 13 years of clinical experience providing preventive healthcare, chronic disease management, and comprehensive medical care.

His expertise includes diabetes management, hypertension, preventive medicine, treatment of acute illnesses, and long-term management of chronic health conditions. Dr. Huang provides care in English and Spanish.

His experience managing diabetes and related metabolic conditions is relevant to Foundayo prescription evaluations, medication monitoring, and comprehensive weight-related health assessments.

Book an appointment online to inquire about Foundayo prescription evaluations with DFWPMA’s medical providers in Fort Worth.

What Can a Foundayo Prescription in Fort Worth Help With?

Foundayo (orforglipron) is a once-daily oral GLP-1 receptor agonist approved for chronic weight management in eligible adults with obesity or overweight and a related medical condition. It helps regulate appetite, reduce food intake, and support weight loss alongside dietary changes and physical activity.

At DFWPMA Fort Worth, Foundayo prescription evaluations address:

  • Obesity Treatment: Supporting chronic weight management in adults with a BMI of 30 or higher.
  • Overweight With Related Health Conditions: Treating eligible adults with a BMI of 27 or higher and a weight-related medical condition.
  • Chronic Weight Management: Supporting clinically meaningful weight loss and long-term weight maintenance.
  • Appetite Regulation: Reducing hunger and food intake through GLP-1 receptor activation.
  • Weight-Related Metabolic Conditions: Supporting weight management in eligible patients with hypertension, high cholesterol, or type 2 diabetes.
  • Oral Weight Loss Medication: Providing a daily pill option for eligible adults who prefer not to use injectable GLP-1 medications.
  • Weight Management After Previous Treatment: Evaluating Foundayo when lifestyle interventions or previous treatments have produced insufficient results.

Foundayo activates GLP-1 receptors involved in appetite regulation, helping patients feel fuller and consume fewer calories. Unlike injectable GLP-1 medications, Foundayo is taken orally once daily, with or without food.

The American College of Physicians recognizes GLP-1-based medications as treatment options for eligible adults with obesity or overweight and associated medical conditions. Medication selection should consider individual benefits, risks, and treatment goals.

Source: American College of Physicians – Pharmacologic Treatments for Overweight and Obesity

Foundayo is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN2. Important risks include pancreatitis, severe gastrointestinal reactions, dehydration-related kidney injury, gallbladder disease, and medication interactions.

Foundayo should not be combined with other GLP-1 receptor agonists. Patients seeking oral weight-loss treatment should discuss whether Foundayo or another approved medication best fits their medical needs.

Schedule an appointment to discuss Foundayo prescription eligibility at DFWPMA Fort Worth.

What Foundayo Prescription Services Are Available at DFWPMA Fort Worth?

DFWPMA Fort Worth provides Foundayo prescription evaluations, weight and metabolic health assessments, medication safety reviews, treatment planning, and ongoing monitoring through endocrinology, internal medicine, and family medicine providers.

Our Foundayo prescription services include:

  • Initial Foundayo Prescription Evaluation: Reviewing BMI, medical history, weight-related conditions, and treatment eligibility.
  • Weight and Metabolic Health Testing: Assessing weight, blood glucose, cholesterol, and relevant metabolic markers.
  • Medication and Contraindication Review: Identifying medication interactions, contraindications, and potential health risks.
  • Foundayo Prescription and Treatment Planning: Prescribing Foundayo when medically appropriate and establishing weight-management goals.
  • Starting Dose and Titration: Adjusting daily dosage according to prescribing guidance, treatment response, and tolerance.
  • Side Effect Monitoring: Assessing gastrointestinal symptoms, dehydration, and other adverse reactions.
  • Weight Loss and Treatment Response Monitoring: Tracking weight changes, medication effectiveness, and treatment progress.
  • Long-Term Weight and Metabolic Care: Managing obesity-related health conditions and supporting sustained weight management.
  • Alternative Weight Loss Medication Evaluation: Considering other approved medications when Foundayo is unsuitable.
  • Follow-Up and Coordinated Care: Providing continued medical supervision and specialty referrals when needed.

Foundayo typically starts at 0.8 mg once daily, increasing to 2.5 mg after at least 30 days and then to 5.5 mg after another 30 days. Further adjustments depend on treatment response and tolerance, up to a maximum of 17.2 mg daily.

Common side effects include nausea, constipation, diarrhea, vomiting, and abdominal discomfort. Severe abdominal pain, significant dehydration, or allergic reactions require prompt medical attention. Foundayo may also affect certain oral medications, including hormonal contraceptives.

The American College of Physicians emphasizes individualized weight-management decisions that consider medication benefits, risks, costs, medical conditions, and long-term health goals.

Source: American College of Physicians – Pharmacologic Treatments for Overweight and Obesity

Not every patient qualifies for Foundayo. A medical evaluation determines whether the medication or an alternative treatment is appropriate. Foundayo should be discontinued if pregnancy occurs.

Looking for a Foundayo prescription in Fort Worth? Book an appointment or call (903) 957-0082 to schedule your evaluation at DFWPMA.